| mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.00059 |
1 |
| mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
-0.00042 |
1 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00041 |
1 |
| mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.00033 |
1 |
| mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.00027 |
1 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.00026 |
1 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.00011 |
1 |
| mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-6.1e-05 |
1 |
| mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
2.9e-05 |
1 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
1.2e-05 |
1 |